methylprednisolone has been researched along with Movement Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Aarabi, B; Badhiwala, JH; Fehlings, MG; Geisler, FH; Grossman, RG; Harrop, JS; Vaccaro, AR; Wilson, JR; Witiw, CD | 1 |
| Goenka, A; Jain, V; Nariai, H; Spiro, A; Steinschneider, M | 1 |
| Armangue, T; Cantarín-Extremera, V; Duat-Rodríguez, A; González-Gutiérrez-Solana, L; López-Marín, L | 1 |
| Garcia-Estevez, DA | 1 |
| Abdool, K; Dyaanand, H; Persad, N; Ramcharan, K | 1 |
| Fernandes, J; Ferreira, C; Machado, A; Rocha, J; Rodrigues, M | 1 |
| Kitazawa, Y; Koide, R; Kuroda, M; Tanaka, K; Uruha, A | 1 |
| Della Giustina, E; Frattini, D; Fusco, C; Pisani, F; Ucchino, V | 1 |
| Bandeira, M; Borlot, F; Kok, F; Liberalesso, PB; Löhr, A; Reed, UC; Santos, ML | 1 |
| Borlongan, CV; Hess, DC; Yu, G | 1 |
| Chiba, J; Ishigatsubo, Y; Kato, K; Nagaoka, S; Nose, K; Okubo, T; Sakamoto, H; Tani, K | 1 |
| Caglar, M; Ersoy, F; Gunay, M; Gurgey, A; Kale, G; Kucukali, T; Sayli, T | 1 |
| del Olmo, A; González, A; Taberner, P; Tornero, C | 1 |
| Blunt, SB; Lane, RJ; Perkin, GD; Turjanski, N | 1 |
| Abe, K; Kashihara, K; Marui, K; Takahashi, K; Tanimoto, Y | 1 |
| Chikawa, T; Fukuzawa, K; Hamada, Y; Ikata, T; Katoh, S; Kogure, K | 1 |
| Oldham, R; Roy, S | 1 |
| Ducker, TB; Hamit, HF | 1 |
18 other study(ies) available for methylprednisolone and Movement Disorders
| Article | Year |
|---|---|
The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cervical Vertebrae; Decompression, Surgical; Disability Evaluation; Endpoint Determination; Female; Humans; Male; Methylprednisolone; Middle Aged; Movement Disorders; Neurosurgical Procedures; Prospective Studies; Recovery of Function; Sensation; Spinal Cord Injuries; Time-to-Treatment; Treatment Outcome; Young Adult | 2021 |
Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.
Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Child, Preschool; Disease Progression; Female; Hallucinations; Humans; Immunoglobulins, Intravenous; India; Infant; Male; Methylprednisolone; Movement Disorders; Seizures; Sleep Initiation and Maintenance Disorders; Symptom Assessment; Treatment Outcome; Young Adult | 2017 |
Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder.
Topics: Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Deglutition Disorders; Humans; Hyperkinesis; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Movement Disorders; Prednisone; Psychomotor Agitation; Stupor; Tetrabenazine; Treatment Outcome | 2013 |
[Cervicodorsal myelitis secondary to infection by varicella zoster virus in an immunocompetent patient].
Topics: Acyclovir; Antiviral Agents; Arm; Athetosis; Bromodeoxyuridine; Drug Therapy, Combination; Herpes Zoster; Herpesvirus 3, Human; Humans; Hyperalgesia; Immunocompetence; Male; Methylprednisolone; Middle Aged; Movement Disorders; Myelitis; Neck; Neuralgia, Postherpetic; Somatosensory Disorders; Thorax; Virus Activation | 2013 |
Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Movement Disorders; Mycophenolic Acid; Prednisolone | 2015 |
The groom who could not say "I do".
Topics: Adult; Anti-Inflammatory Agents; Cranial Nerve Diseases; Facial Asymmetry; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Oligoclonal Bands; Prednisone | 2010 |
Anti-NMDAR encephalitis in small-cell lung cancer: a case report.
Topics: Acyclovir; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antimetabolites; Fatal Outcome; Humans; Lung Neoplasms; Male; Mental Disorders; Meropenem; Methylprednisolone; Movement Disorders; Small Cell Lung Carcinoma; Thienamycins | 2012 |
Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea.
Topics: Adrenal Cortex Hormones; Age of Onset; Anti-Inflammatory Agents; Anticonvulsants; Antipsychotic Agents; Antistreptolysin; Child; Chorea; Deglutition; Female; Humans; Male; Mastication; Methylprednisolone; Movement Disorders; Myocarditis; Neurologic Examination; Paralysis; Pregnenediones; Rheumatic Fever | 2012 |
Anti-N-methyl D-aspartate receptor encephalitis in childhood.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Immunosuppression Therapy; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Seizures; Speech Disorders | 2012 |
Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome | 2004 |
[A case of systemic lupus erythematosus with akinesia, muscle rigidity and neurogenic bladder].
Topics: Adult; Antiparkinson Agents; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Movement Disorders; Muscle Rigidity; Urinary Bladder, Neurogenic | 1984 |
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement.
Topics: Albinism; Central Nervous System Diseases; Child; Etoposide; Female; Fever; Humans; Leukopenia; Methylprednisolone; Movement Disorders; Syndrome; Thrombocytopenia | 1994 |
[Mixed polyneuropathy as a form of presentation of serologically AACN-P positive microscopic panarteritis].
Topics: Aged; Arthritis; Aspirin; Autoantibodies; Blood Chemical Analysis; Cytoplasm; Diagnosis, Differential; Electromyography; Female; Humans; Methylprednisolone; Movement Disorders; Neutrophils; Vasculitis | 1994 |
Clinical features and management of two cases of encephalitis lethargica.
Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Encephalitis; Female; Humans; Injections, Intravenous; Methylprednisolone; Movement Disorders; Myoclonus; Sleep Stages | 1997 |
Inflammatory demyelinating polyradiculoneuropathy associated with interstitial lung disease.
Topics: Anti-Inflammatory Agents; Female; Guillain-Barre Syndrome; Humans; Lung; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Movement Disorders; Radiography, Thoracic; Recurrence; Sensation Disorders; Tomography, X-Ray Computed | 2000 |
Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes.
Topics: Animals; Gene Expression Regulation; Glycerol-3-Phosphate Dehydrogenase (NAD+); Glycerolphosphate Dehydrogenase; Intercellular Adhesion Molecule-1; Interleukin-1; Male; Methylprednisolone; Movement Disorders; Myelitis; Nerve Growth Factors; Neurotrophin 3; Nitric Oxide Synthase; Phosphatidylcholines; Rats; Rats, Wistar; Recovery of Function; RNA, Messenger; Spinal Cord Injuries; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Transcription, Genetic | 2001 |
Management of painful shoulder.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Male; Methylprednisolone; Middle Aged; Movement Disorders; Pain; Shoulder Joint; Syndrome | 1976 |
Experimental treatments of acute spinal cord injury.
Topics: Acute Disease; Animals; Dexamethasone; Dogs; Edema; Female; Gelatin Sponge, Absorbable; Hypothermia, Induced; Injections, Intramuscular; Injections, Spinal; Male; Methylprednisolone; Movement Disorders; Spinal Cord; Spinal Cord Injuries | 1969 |